Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
Treatment of metastatic prostate cancer.
As adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer.
As neoadjuvant treatment prior to radiotherapy in patients with high-risk localized or locally advanced prostate cancer.
As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
Treatment of endometriosis.
Treatment of uterine fibroids prior to surgery or when surgery is not appropriate.